Discovery Chemistry & Drug Design Congress 2013

Oxford Global Conferences are proud to present the Discovery Chemistry & Drug Design Congress taking place on 10 & 11 June in Geneva. This congress is the latest addition to our long-established 14th Annual Drug Discovery Summit. Focused on the latest breakthroughs in discovery chemistry, it will bring together the industry leaders in medicinal chemistry and drug design.

The discovery industry faces a decade of monumental change – stem cell research, gene therapy approvals, virtual R&D models and a growing focus on biological pipelines are just a few of the factors changing the way we approach drug discovery. Our expert speaker panel will explore the critical concerns in discovery chemistry today, while updating key decision makers on the latest developments in drug design.

Day One will feature presentations on lead optimisation, structure-activity relationships and fragment-based drug discovery. Our internationally renowned speakers will also discuss the latest developments in drug design, including anti-target modelling, advances in polypharmacology and structure based design.

The event will be co-located with the Innovation Driven Discovery Congress; a high-level meeting focused on novel approaches to drug discovery and collaborative working methods. Delegates will also be able to attend the co-located Drug Development Congress; a two stream event for those working at the forefront of research, development and translational medicine.

For more information on the agenda or registration enquiries please email: d.meredith@oxfordglobal.co.uk